Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in Japan. Issue 12 (21st December 2021)

• Record Type: Journal Article
• Authors: Ikezaki, Hiroaki; Furusyo, Norihiro; Nakashima, Ryoko; Umemoto, Makiko; Yamamoto, Ken; Matsumoto, Yuji; Ohta, Azusa; Yamasaki, Sho; Hiramine, Satoshi; Takayama, Koji; Ogawa, Eiichi; Toyoda, Kazuhiro; Murata, Masayuki; Shimono, Nobuyuki; Hayashi, Jun
• Is Part Of: BMJ open. Volume 11:Issue 12(2021)
• Publication Date: 2021-12-21
• Subjects: epidemiology -- lipid disorders -- cardiology; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2021-053763
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Purpose: The Kyushu and Okinawa Population Study (KOPS) was established to investigate gene–environmental interactions in non-communicable diseases in Japan. Besides collecting blood samples and anthropometric measurements, we also obtained medical histories, psychological status and lifestyle habits, including physical activities and dietary patterns. Participants: KOPS is a community-based prospective cohort study and consists of participants from four southwestern areas in Japan. Baseline surveys were conducted between 2004 and 2007 (wave 1), and 2009 and 2012 (wave 2) at the sites of municipality-based health check-ups. A total of 17 077 participants were included, comprising 10 697 participants of wave 1 and 6380 participants of wave 2; the median age in both groups was 61 years. Among them, 3006 individuals participated in both wave 1 and wave 2 surveys. Findings to date: We have focused on either risk or confounding factors for non-communicable diseases. We have assessed the clinical utility of the newly developed biomarkers for impaired glucose tolerance, such as urinary myo-inositol and glycated albumin, and atherosclerosis, such as small dense low-density lipoprotein cholesterol. We have conducted an international collaborative study with Framingham Offspring Study to investigate ethnic differences in impaired glucose tolerance and cardiovascular diseases. We have found that insulin resistance and deficiency might account for the ethnic differences in impaired glucose tolerance and cardiovascular disease risks. As gene–environmental interaction analyses, we found a synergic effect of interleukin 28B single nucleotide polymorphisms (SNPs) and gender on the spontaneous elimination of hepatitis C, and a beneficial interaction of SNPs of high-density lipoprotein cholesterol and gender on the impact of physical activity. In addition, we reported eight novel loci contributing to the development and severity of coronary artery disease from a large genome-wide association study. Future plans: We plan to investigate further the clinical utility of the newly developed biomarkers and the gene–environmental interactions using prospective data.